Weekend reads: Hydroxychloroquine paper earns correction; company allegedly fakes COVID-19 data; why retractions fail

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: A clinical trial about COVID-19 by a convicted felon A … Continue reading Weekend reads: Hydroxychloroquine paper earns correction; company allegedly fakes COVID-19 data; why retractions fail

A journal publishes a critical letter — then says it was a mistake

On Sept. 17, 2019, virologist David Sanders — who recently won a lawsuit brought against him for efforts as a scientific sleuth — wrote a letter to the Journal of Cellular Physiology about a 2004 paper whose images raised his eyebrows. The response a day later from an editorial assistant was a hint of what … Continue reading A journal publishes a critical letter — then says it was a mistake

‘[A] disappointing situation’: Stem cell group retracts with ‘rectitude’ after error

A team of stem cell researchers at the University of Maryland has lost a 2020 paper after failing to correct an error that they’d caught prior to submission. The paper, “Endothelial/mesenchymal stem cell crosstalk within bioprinted coculture,” appeared in Tissue Engineering Part A, a Mary Ann Liebert publication. The senior author of the article was … Continue reading ‘[A] disappointing situation’: Stem cell group retracts with ‘rectitude’ after error

‘Patterns in the data have led to questions’: Ob-gyns lose another paper

A group of OB/GYNs in the Middle East with a history of testing the patience of editors has lost a paper — and received in expression of concern for another — over concerns about the validity of their data.  The articles appeared in the BJOG, a Wiley publication. Both were led by Mohammad Maher, who … Continue reading ‘Patterns in the data have led to questions’: Ob-gyns lose another paper

French hydroxychloroquine-COVID-19 study withdrawn

The authors of a preprint on use of hydroxychloroquine — the controversial drug heavily promoted by, and now apparently taken by, President Trump, at least for a few more days — along with azithromycin for COVID-19 have withdrawn the paper. The preprint, “Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 … Continue reading French hydroxychloroquine-COVID-19 study withdrawn

Weekend reads: Revelations about a controversial COVID-19 study; weaponizing uncertainty; a ‘super-spotter’ of duplicated images

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. Sending thoughts to our readers and wishing them the best in this uncertain time. The week … Continue reading Weekend reads: Revelations about a controversial COVID-19 study; weaponizing uncertainty; a ‘super-spotter’ of duplicated images

‘Aggressive’ COVID-19 strains: What it takes to correct a flawed paper

A group of researchers in Scotland have taken aim at a study published in early March which reported surprising findings on the genetics of the SARS-CoV-2 virus responsible for the Covid-19 pandemic.  But the story of what it took to correct the record about the paper is likely to be all too familiar to those … Continue reading ‘Aggressive’ COVID-19 strains: What it takes to correct a flawed paper

Weekend reads: A COVID-19 conspiracy theory; a 15-year-old publishes in NEJM; the need for speed

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. Sending thoughts to our readers and wishing them the best in this uncertain time. The week … Continue reading Weekend reads: A COVID-19 conspiracy theory; a 15-year-old publishes in NEJM; the need for speed

The circle of life, publish or perish edition: Two journals retract more than 40 papers

Talk about the publish-or-perish version of the circle of life. A Springer Nature journal has retracted 33 articles — 29 from one special issue, and four from another — for a laundry list of publishing sins, from fake peer review to plagiarism to stealing unpublished manuscripts. And an Elsevier journal has retracted ten papers recently … Continue reading The circle of life, publish or perish edition: Two journals retract more than 40 papers

Weekend reads: Retracted COVID-19 papers; a coronavirus study kept under wraps; Harvard and Jeffrey Epstein

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. Sending thoughts to our readers and wishing them the best in this uncertain time. The week … Continue reading Weekend reads: Retracted COVID-19 papers; a coronavirus study kept under wraps; Harvard and Jeffrey Epstein